GSK earnings
GSK (GSK) next earnings date and estimates, and its past reports: EPS against estimates, the surprise and revenue.
GSK earnings history
| Quarter | Reported | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|---|
| Q3 2026 | Oct 28, 2026 | 1.47 | 1.33 | 10.53% | $8.82B |
| Q2 2026 | Jul 28, 2026 | 1.36 | 1.27 | 7.09% | $8.41B |
| Q1 2026 | Apr 29, 2026 | 1.24 | 1.16 | 6.90% | $7.63B |
| Q4 2025 | Feb 4, 2026 | 0.68 | 0.64 | 6.25% | $8.62B |
| Q3 2025 | Oct 29, 2025 | 1.48 | 1.26 | 17.46% | $8.55B |
| Q2 2025 | Jul 30, 2025 | 1.23 | 1.12 | 9.82% | $7.99B |
| Q1 2025 | Apr 30, 2025 | 1.13 | 1.08 | 4.63% | $7.52B |
| Q4 2024 | Feb 4, 2025 | 0.59 | 0.44 | 34.09% | $8.12B |
| Q3 2024 | Oct 30, 2024 | 1.27 | 1.16 | 9.48% | $8.01B |
| Q2 2024 | Jul 31, 2024 | 1.09 | 1.00 | 9.00% | $7.88B |
| Q1 2024 | May 1, 2024 | 1.09 | 0.91 | 19.78% | $7.36B |
| Nov 1, 2023 | 1.26 | 1.09 | 15.60% | – | |
| Jul 26, 2023 | 0.97 | 0.85 | 14.12% | – | |
| Apr 26, 2023 | 0.90 | 0.85 | 5.88% | – | |
| Feb 1, 2023 | 0.64 | 0.59 | 8.47% | – | |
| Nov 2, 2022 | 1.09 | 0.90 | 21.11% | – | |
| Jul 27, 2022 | 0.87 | 0.76 | 14.47% | – | |
| Apr 27, 2022 | 1.10 | 0.79 | 39.42% | – | |
| Feb 9, 2022 | 0.86 | 0.79 | 8.86% | – | |
| Oct 27, 2021 | 1.26 | 1.00 | 26.00% | – |
- GSK reports next on Feb 3, 2027, with EPS of 0.32 expected.
- GSK beat EPS estimates in 68 of its last 98 reports.
Updated 2026-11-02 19:54 UTC